Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Jiangsu Kanion Pharmaceutical Co's Days Payable or its related term are showing as below:
SHSE:600557'
s Days Payable Range Over the Past 10 Years
Min: 81.03 Med: 102.74 Max: 143.06
Current: 91.87
During the past 13 years, Jiangsu Kanion Pharmaceutical Co's highest Days Payable was 143.06. The lowest was 81.03. And the median was 102.74.
SHSE:600557's Days Payable is ranked better than 51.46% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:600557: 91.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Kanion Pharmaceutical Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Kanion Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Kanion Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Kanion Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Jiangsu Kanion Pharmaceutical Co's Days Payable falls into.
Jiangsu Kanion Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Kanion Pharmaceutical Co (SHSE:600557) has a Days Payable of 101.56 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jiangsu Kanion Pharmaceutical Co and its competitors. This is near median its historical median of 102.74. Over the past decade, Jiangsu Kanion Pharmaceutical Co's Days Payable has ranged from 81.03 to 143.06. According to the industry distribution chart, Jiangsu Kanion Pharmaceutical Co ranks #450 out of 927 companies in the Drug Manufacturers industry, placing it in the top 48.5%.
Is Jiangsu Kanion Pharmaceutical Co's Days Payable too high?
Jiangsu Kanion Pharmaceutical Co's current Days Payable of 101.56 is near median its 10-year median of 102.74. Over the past 10 years, this metric has ranged from a low of 81.03 to a high of 143.06. The Drug Manufacturers industry median Days Payable is 90.38. Jiangsu Kanion Pharmaceutical Co's value of 101.56 is 12.4% above this industry median. Based on the distribution chart, Jiangsu Kanion Pharmaceutical Co ranks #450 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jiangsu Kanion Pharmaceutical Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Kanion Pharmaceutical Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Kanion Pharmaceutical Co ranks #450 out of 927 companies for Days Payable. This puts Jiangsu Kanion Pharmaceutical Co in the upper half of its industry. The industry median Days Payable is 90.38. Jiangsu Kanion Pharmaceutical Co's value of 101.56 is 12.4% above this benchmark. Historically, Jiangsu Kanion Pharmaceutical Co's own Days Payable has ranged from 81.03 to 143.06 over the past decade. While the company's 10-year median is 102.74 vs. the industry median of 90.38, Jiangsu Kanion Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Kanion Pharmaceutical Co's current Days Payable of 101.56 is 12.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jiangsu Kanion Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Kanion Pharmaceutical Co's current Days Payable is 101.56, which is near median its own 10-year median of 102.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Kanion Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Kanion Pharmaceutical Co (SHSE:600557) is currently considered Fairly Valued. The stock's GF Value™ is ¥13.70, compared to a current price of ¥13.63 — trading 0.5% below its estimated fair value. The current Days Payable is 101.56, which is near median its 10-year median of 102.74 and 12.4% above the Drug Manufacturers industry median of 90.38. Jiangsu Kanion Pharmaceutical Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jiangsu Kanion Pharmaceutical Co (SHSE:600557), the current Days Payable is 101.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Kanion Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥13.63 is trading 0.5% below its estimated GF Value™ of ¥13.70.
GuruFocus considers Jiangsu Kanion Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:600557:
Days Payable: 101.56 (near median its 10-year median of 102.74)
GF Value™: ¥13.70 vs. price of ¥13.63 (0.5% below fair value)
Industry Position: 12.4% above the Drug Manufacturers median (#450 of 927)
No single metric tells the full story. See the SHSE:600557 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Kanion Pharmaceutical Co Business Description
Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.
82GF Score
Get the complete analysis for SHSE:600557
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600557 has been successfully added to your 
